Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Equitable Holdings Inc. Common Stock (EQH) vs Nomura Holdings Inc (NMR) Price & Performance

Equitable Holdings Inc. Common StockTrade
Nomura Holdings IncTrade

Price performance (Past 24H)

Key statistics

Equitable Holdings Inc. Common Stock vs Nomura Holdings Inc — how do they compare? Equitable Holdings Inc. Common Stock trades at $52.77 (market cap $14.49B), while Nomura Holdings Inc trades at $9.2 (market cap $28.01B). The key difference: Nomura Holdings Inc is the larger of the two by market cap, and Nomura Holdings Inc pays the higher dividend (3.38%). Which is the better fit depends on your goals — on Pluang, investors hold Equitable Holdings Inc. Common Stock for 0 Days and Nomura Holdings Inc for 56 Days on average.

EQHNMR
Market Cap
$14.49B$28.01B
Volume
2,405,401686,801
Sector
FinancialsFinancials
52-Week High
$54.50$10.86
52-Week Low
$35.34$6.92
Typical Hold Time
0 Days56 Days
Enterprise Value
$5.54B$38.48T
Dividend Yield
2.15%3.38%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Equitable Holdings Inc. Common Stock

Equitable Holdings (EQH) trades at $53.12, down 0.75% on the day, with strong analyst support (95% buy ratings) and a $64.71 consensus price target suggesting 22% upside. Recent quarterly earnings have consistently beaten expectations, though the company reported a net loss of $1.38B for 2025. The planned merger with Corebridge and expansion into fee-based businesses are key growth drivers, while high debt-to-asset ratio of 2.07 presents financial risk.

EQH shows mixed fundamentals with positive earnings momentum but negative profitability metrics. The stock offers significant upside potential based on analyst targets, supported by strategic initiatives and dividend appeal. Key risks include execution of the Corebridge merger, persistent net losses, and high leverage. Investors should weigh strong analyst conviction against fundamental weaknesses.

Nomura Holdings Inc

Nomura Holdings (NMR) trades at $9.26, down 3.24% with bearish technical signals. The stock shows mixed earnings performance with recent misses but strong revenue growth from $1.66T in 2025. Valuation appears attractive with P/E of 11.37 and P/B of 1.16, while analyst sentiment leans cautious with 67% hold ratings. Recent Zacks coverage highlights momentum potential and hammer chart pattern formation.

Outlook remains balanced with fundamental strength in profitability margins (20.4% net income) offset by technical weakness. Investment opportunity lies in discounted valuation amid earnings growth, while risks include cash flow volatility and rising debt levels. The stock requires careful monitoring of Q3 2026 earnings results for directional clarity.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

EQH
100% Buy0% Sell
Avg holding period · 0 Days
NMR
77% Buy23% Sell
Avg holding period · 56 Days

About Equitable Holdings Inc. Common Stock

Equitable Holdings, Inc. is a financial services holding company operating through Equitable, AllianceBernstein, and Equitable Advisors. It provides retirement and protection products, asset and wealth management services, and financial planning through a network of registered financial professionals.

Read more on EQH →

About Nomura Holdings Inc

Nomura is Japan's largest broker, about twice the size of rival Daiwa Securities and roughly three times the size of the securities units of the three megabanks. It is also the largest asset-management company in Japan, with a similar size differential compared with its rivals. Despite its topnotch brand name in retail broking and asset management in Japan, Nomura has struggled to compete effectively in the institutional securities business against larger global rivals. In 2008, Nomura bought European and Asian assets of the failed Lehman Brothers, which led to a sharply higher cost base but did not provide commensurate revenue. Nomura has reduced the scale of these businesses but maintains its ambition to compete globally with the top players.

Read more on NMR →